title: Is it feasible to adjust bisphosphonate dose according to bone mineral density value in postmenopausal breast cancer patients with bone metastases?
authors.forename: Tuncay
authors.initials: T
authors.lastname: Delibasi
authors.forename: Nuri I
authors.initials: NI
authors.lastname: Akkus
authors.forename: Ozden
authors.initials: O
authors.lastname: Altundag
authors.forename: Tevfik
authors.initials: T
authors.lastname: Pinar
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D015519:Bone Density / Q000187:drug effects*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage; D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000556:secondary*; D004164:Diphosphonates / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates